๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Potentiation of growth inhibition due to vincristine by ascorbic acid in a resistant human non-small cell lung cancer cell line

โœ Scribed by Eing-Ju, Song; Yang, Vie Cheng; Chiang, Chi Der; Chao, Chuck C.-K.

Book ID
122447064
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
643 KB
Volume
292
Category
Article
ISSN
0926-6917

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Establishment of a human non-small cell
Establishment of a human non-small cell lung cancer cell line resistant to gefitinib
โœ Fumiaki Koizumi; Tatsu Shimoyama; Fumiko Taguchi; Nagahiro Saijo; Kazuto Nishio ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 672 KB

## Abstract The epidermal growth factor receptor (EGFR) tyrosineโ€kinase inhibitor gefitinib (Iressaยฎ, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drugโ€resistant sublines with their parental cells are useful approaches to identifying the m

Human endostatin inhibits growth of huma
Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant model
โœ Arnd Steffen Boehle; Roland Kurdow; Maren Schulze; Ursula Kliche; Bence Sipos; K ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 261 KB ๐Ÿ‘ 1 views

Overall prognosis in human NSCLC remains poor. Antiangiogenic treatment has become a promising concept for the treatment of solid malignancies. Our purpose was to evaluate the efficacy of recombinant HSENDO for the treatment of human NSCLC in an orthotopic murine xenotransplantation model. The effic